| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |